Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lindsley

Showing results (331-340 of 570) with videos related to

Pageof 57
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 24, 2012
Yohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processesKelly L Conrad, Adeola R Davis, Yuval Silberman, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2021
Discovery of a novel class of heteroaryl-pyrrolidinones as positive allosteric modulators of the muscarinic acetylcholine receptor M<sub>1</sub>Paul K Spearing, Hyekyung P Cho, Vincent B Luscombe, et al.
Bioorganic & Medicinal Chemistry Letters|August 23, 2012
Identification of (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide, ML277, as a novel, potent and selective K(v)7.1 (KCNQ1) potassium channel activatorMargrith E Mattmann, Haibo Yu, Zhihong Lin, et al.
ACS Chemical Neuroscience|May 18, 2016
ML418: The First Selective, Sub-Micromolar Pore Blocker of Kir7.1 Potassium ChannelsDaniel R Swale, Haruto Kurata, Sujay V Kharade, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 2, 2020
Modulation of arousal and sleep/wake architecture by M<sub>1</sub> PAM VU0453595 across young and aged rodents and nonhuman primatesRobert W Gould, Jason K Russell, Michael T Nedelcovych, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2021
Positive allosteric modulators (PAMs) of the group II metabotropic glutamate receptors: Design, synthesis, and evaluation as ex-vivo tool compoundsYousuke Yamada, Kristen Gilliland, Zixiu Xiang, et al.
Molecular Pharmacology|October 8, 2010
Development of a selective small-molecule inhibitor of Kir1.1, the renal outer medullary potassium channelGautam Bhave, Brian A Chauder, Wen Liu, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|December 5, 2016
Discoidin domain receptor 1 kinase activity is required for regulating collagen IV synthesisCorina M Borza, Yan Su, Truc-Linh Tran, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitorsZhijian Zhao, William H Leister, Ronald G Robinson, et al.
The Journal of Clinical Investigation|November 16, 2013
Inhibition of the TRPC5 ion channel protects the kidney filterThomas Schaldecker, Sookyung Kim, Constantine Tarabanis, et al.
Pageof 57

Showing results (331-340 of 570) with videos related to

Sort By:
Pageof 57
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 24, 2012
Yohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processesKelly L Conrad, Adeola R Davis, Yuval Silberman, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2021
Discovery of a novel class of heteroaryl-pyrrolidinones as positive allosteric modulators of the muscarinic acetylcholine receptor M<sub>1</sub>Paul K Spearing, Hyekyung P Cho, Vincent B Luscombe, et al.
Bioorganic & Medicinal Chemistry Letters|August 23, 2012
Identification of (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide, ML277, as a novel, potent and selective K(v)7.1 (KCNQ1) potassium channel activatorMargrith E Mattmann, Haibo Yu, Zhihong Lin, et al.
ACS Chemical Neuroscience|May 18, 2016
ML418: The First Selective, Sub-Micromolar Pore Blocker of Kir7.1 Potassium ChannelsDaniel R Swale, Haruto Kurata, Sujay V Kharade, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 2, 2020
Modulation of arousal and sleep/wake architecture by M<sub>1</sub> PAM VU0453595 across young and aged rodents and nonhuman primatesRobert W Gould, Jason K Russell, Michael T Nedelcovych, et al.
Bioorganic & Medicinal Chemistry Letters|August 30, 2021
Positive allosteric modulators (PAMs) of the group II metabotropic glutamate receptors: Design, synthesis, and evaluation as ex-vivo tool compoundsYousuke Yamada, Kristen Gilliland, Zixiu Xiang, et al.
Molecular Pharmacology|October 8, 2010
Development of a selective small-molecule inhibitor of Kir1.1, the renal outer medullary potassium channelGautam Bhave, Brian A Chauder, Wen Liu, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|December 5, 2016
Discoidin domain receptor 1 kinase activity is required for regulating collagen IV synthesisCorina M Borza, Yan Su, Truc-Linh Tran, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Discovery of 2,3,5-trisubstituted pyridine derivatives as potent Akt1 and Akt2 dual inhibitorsZhijian Zhao, William H Leister, Ronald G Robinson, et al.
The Journal of Clinical Investigation|November 16, 2013
Inhibition of the TRPC5 ion channel protects the kidney filterThomas Schaldecker, Sookyung Kim, Constantine Tarabanis, et al.
Pageof 57